We are live on ! Find out more
Zurich Cantonal Bank

Zurich Cantonal Bank Portfolio holdings

AUM $46B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
-2.82%
1 Year Est. Return
+27.59%
3 Year Est. Return
+97.89%
5 Year Est. Return
+132.69%
10 Year Est. Return
+500.34%
AUM
$20.3B
AUM Growth
-$365M
Cap. Flow
+$648M
Cap. Flow %
3.19%
Top 10 Hldgs %
26.97%
Holding
2,921
New
57
Increased
957
Reduced
718
Closed
195

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$81.9M
2
CSCO icon
Cisco
CSCO
+$60.5M
3
ATKR icon
Atkore
ATKR
+$43M
4
BNS icon
Scotiabank
BNS
+$40.3M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$38M

Top Sells

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$50.9M
2
SIVB
SVB Financial Group
SIVB
+$35.9M
3
TMUS icon
T-Mobile US
TMUS
+$33.6M
4
APTV icon
Aptiv
APTV
+$28M
5
XLNX
Xilinx Inc
XLNX
+$26.9M

Sector Composition

Rank Sector Weight
1 Technology 25.3%
2 Financials 15.57%
3 Healthcare 14.62%
4 Consumer Discretionary 10.14%
5 Industrials 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRIS icon
2601
Curis
CRIS
$4.62M
$24K ﹤0.01%
25
HCI icon
2602
HCI Group
HCI
$2.31B
$24K ﹤0.01%
355
OLMA icon
2603
Olema Pharmaceuticals
OLMA
$900M
$24K ﹤0.01%
5,655
URTY icon
2604
ProShares UltraPro Russell2000
URTY
$355M
$24K ﹤0.01%
305
MRNS
2605
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$24K ﹤0.01%
+2,609
New +$25.9K
ABCM
2606
DELISTED
Abcam PLC
ABCM
$24K ﹤0.01%
+1,316
New +$23.3K
BCYC
2607
Bicycle Therapeutics
BCYC
$289M
$23K ﹤0.01%
+535
New +$25K
DSGN icon
2608
Design Therapeutics
DSGN
$909M
$23K ﹤0.01%
+1,448
New +$22.2K
FAS icon
2609
Direxion Daily Financial Bull 3x ETF
FAS
$2.46B
$23K ﹤0.01%
180
ANIP icon
2610
ANI Pharmaceuticals
ANIP
$1.72B
$22K ﹤0.01%
794
BP icon
2611
BP
BP
$111B
$22K ﹤0.01%
760
TCRT icon
2612
Alaunos Therapeutics
TCRT
$4.79M
$22K ﹤0.01%
221
YMAB
2613
DELISTED
Y-mAbs Therapeutics
YMAB
$22K ﹤0.01%
1,868
QTTB icon
2614
Q32 Bio
QTTB
$453M
$22K ﹤0.01%
397
PBR icon
2615
Petrobras
PBR
$115B
$21K ﹤0.01%
1,408
-18,469
-93% -$248K
SDC
2616
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$21K ﹤0.01%
8,115
RMO
2617
DELISTED
Romeo Power, Inc.
RMO
$21K ﹤0.01%
14,341
PGEN icon
2618
Precigen
PGEN
$2.47B
$20K ﹤0.01%
9,507
-5,374
-36% -$13.1K
ALPN
2619
DELISTED
Alpine Immune Sciences Inc
ALPN
$20K ﹤0.01%
+2,257
New +$19.5K
OYST
2620
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$20K ﹤0.01%
+1,697
New +$20.2K
MGTX icon
2621
MeiraGTx Holdings
MGTX
$1.2B
$19K ﹤0.01%
+1,352
New +$20.8K
MUX icon
2622
McEwen Inc
MUX
$1.17B
$19K ﹤0.01%
2,206
RAPT
2623
DELISTED
RAPT Therapeutics
RAPT
$19K ﹤0.01%
+107
New +$20.2K
REX icon
2624
REX American Resources
REX
$1.44B
$19K ﹤0.01%
1,116
RUBY
2625
DELISTED
Rubius Therapeutics, Inc
RUBY
$19K ﹤0.01%
3,374
-6,561
-66% -$41.7K

Similar funds

Zurich Cantonal Bank's Q1 2022 Portfolio in Review

As of Q1 2022, Zurich Cantonal Bank held 2,921 positions worth $20.3B, down 1.8% from $20.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Zurich Cantonal Bank deployed $648M of net new capital in Q1 2022, opening 57 new positions and adding to 957 existing holdings. Its largest new stake was Amplify Travel Tech ETF: 21,900 shares worth $523K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was UBS Group, an estimated $50.9M trimmed.

  • Zurich Cantonal Bank's largest Q1 2022 buy was Amplify Travel Tech ETF: 21,900 shares worth $523K.
  • Zurich Cantonal Bank added most to Verizon in Q1 2022, an estimated $81.9M increase.
  • Zurich Cantonal Bank's biggest Q1 2022 reduction was UBS Group, cutting an estimated $50.9M.
  • Zurich Cantonal Bank fully exited Xilinx Inc in Q1 2022, selling an estimated $26.9M.
  • Zurich Cantonal Bank's ten largest holdings make up 27% of its $20.3B portfolio in Q1 2022.
  • Zurich Cantonal Bank opened 57 new positions and closed 195 in Q1 2022.
  • Zurich Cantonal Bank's portfolio value fell 1.8% quarter-over-quarter to $20.3B.

Based on Zurich Cantonal Bank's 13F filing for Q1 2022, filed 21 Apr 2022.